https://www.selleckchem.com/products/icg-001.html
Oligometastatic colorectal cancer (CRC) is potentially curable and demands individualised strategies. This single-centre retrospective study investigated if positron emission tomography (PET)/magnetic resonance imaging (MR) had a clinical impact on oligometastatic CRC relative to the standard of care imaging (SCI). Adult patients with oligometastatic CRC on SCI who also underwent PET/MR between 3/2016 and 3/2019 were included. The exclusion criterion was lack of confirmatory standard of reference, either surgical pathology, intraoperati
כמו
תגובה
לַחֲלוֹק
